Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 22, 2021
Event Date: March 17, 2021 (Closing Date)
Context: The Company entered into a new Credit Agreement to refinance existing debt facilities and redeem outstanding senior notes.
Key Financial Metrics and Debt Structure
This filing details a significant restructuring of the Company's debt capitalization rather than reporting operational financial results (revenue, profit, or cash flow) for a specific period.
| Facility Type | Amount | Maturity Date |
|---|---|---|
| Senior Secured Revolving Credit Facility | $600 million | March 17, 2026 |
| Senior Secured Term Loan Facility | $425 million | March 17, 2026 |
| Letters of Credit Sub-limit | Up to $20 million | N/A |
| Swingline Facility | Up to $20 million | N/A |
Interest Rates: Floating rate based on adjusted LIBOR plus 1.75% or an alternative base rate plus 0.750%, subject to leverage ratio adjustments.
Unused Fee: Initially 0.25% per annum on the undrawn portion of the Revolving Facility.
Use of Proceeds: Refinance existing credit facilities, redeem all outstanding 5.625% senior notes due 2023, and fund working capital/general corporate purposes.
Material Changes Versus Prior Period
- Termination of Prior Debt: The Company terminated its existing credit facilities under the Amended and Restated Credit Agreement dated December 31, 2012. No early termination fees were incurred.
- Debt Redemption: Proceeds were utilized to finance the redemption of all outstanding 5.625% senior notes due 2023.
- Increased Capacity: The new agreement provides a total of $1.025 billion in senior secured facilities, replacing the prior structure.
- Extension of Maturity: The new facilities mature in 2026, extending the debt maturity profile compared to the 2023 notes being redeemed.
Guidance, Covenants, and Risks
Financial Covenants:
- Consolidated Total Net Leverage Ratio: Must not exceed 5.0 to 1.0 (steps down to 4.75 to 1.0 and 4.5 to 1.0; may be increased to 5.0 to 1.0 up to three times for permitted acquisitions).
- Interest Coverage Ratio: Must be at least 3.0 to 1.0.
Incremental Facilities: The Company may increase the Senior Facilities up to the greater of $480 million or 100% of Consolidated EBITDA, provided the Consolidated Senior Secured Net Leverage Ratio does not exceed 3.5 to 1.0.
Risks and Contingencies:
- Events of Default: Customary events of default may result in the acceleration of all outstanding loans and termination of lender commitments.
- Covenants: The agreement includes limitations on incurring additional debt, granting liens, making investments, mergers, asset dispositions, and paying dividends.
- Collateral: Obligations are secured by a pledge of substantially all assets of the Company and Guarantors (excluding real property and certain customarily excluded assets).
Investor Verification Checklist
- Verify the exact amount of cash used to redeem the 5.625% senior notes due 2023 versus the amount borrowed under the new Term Loan Facility.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of "Consolidated EBITDA" and "Consolidated Senior Secured Net Leverage Ratio."
- Confirm the Company's current leverage ratio to assess compliance with the 5.0 to 1.0 covenant immediately following the closing.
- Check subsequent filings for any utilization of the Revolving Facility or Swingline Facility.
- Monitor for any permitted acquisitions that might trigger the temporary increase of the leverage ratio covenant to 5.0 to 1.0.